XML 127 R22.htm IDEA: XBRL DOCUMENT v2.4.0.8
Guarantor Non-Guarantor Subsidiary Financial Information
6 Months Ended
Jun. 30, 2013
Guarantor Non Guarantor Subsidary Financial Information [Abstract]  
Guarantees [Text Block]
Guarantor/Non-Guarantor Subsidiary Financial Information
The Company and certain of its U.S. subsidiaries guarantee debt issued by its wholly owned subsidiaries Hexion Nova Scotia, ULC and Hexion U.S. Finance Corporation (together, the “Subsidiary Issuers”), which includes the 6.625% First-Priority Senior Secured Notes due 2020, 8.875% Senior Secured Notes due 2018 and the 9.00% Second-Priority Senior Secured Notes due 2020.
The following information contains the condensed consolidating financial information for MSC (the parent), the Subsidiary Issuers, the combined subsidiary guarantors (Momentive Specialty Chemical Investments Inc.; Borden Chemical Foundry; LLC, Lawter International, Inc.; HSC Capital Corporation; Momentive International, Inc.; Momentive CI Holding Company; NL COOP Holdings LLC and Oilfield Technology Group, Inc.) and the combined non-guarantor subsidiaries, which includes all of the Company’s foreign subsidiaries.
All of the Subsidiary Issuers and Subsidiary Guarantors are 100% owned by MSC. All guarantees are full and unconditional, and are joint and several. There are no significant restrictions on the ability of the Company to obtain funds from its domestic subsidiaries by dividend or loan. While the Company’s Australian, New Zealand and Brazilian subsidiaries are restricted in the payment of dividends and intercompany loans due to the terms of their credit facilities, there are no material restrictions on the Company’s ability to obtain cash from the remaining non-guarantor subsidiaries.
This information includes allocations of corporate overhead to the combined non-guarantor subsidiaries based on net sales. Income tax expense has been provided on the combined non-guarantor subsidiaries based on actual effective tax rates.
MOMENTIVE SPECIALTY CHEMICALS INC.
JUNE 30, 2013
CONDENSED CONSOLIDATING BALANCE SHEET (Unaudited)
 
 
Momentive
Specialty
Chemicals
Inc.
 
Subsidiary
Issuers
 
Combined
Subsidiary
Guarantors
 
Combined
Non-Guarantor
Subsidiaries
 
Eliminations
 
Consolidated
Assets
 
 
 
 
 
 
 
 
 
 
 
Current assets
 
 
 
 
 
 
 
 
 
 
 
Cash and cash equivalents (including restricted cash of $0 and $3, respectively)
$
225

 
$

 
$

 
$
110

 
$

 
$
335

Short-term investments

 

 

 
6

 

 
6

Accounts receivable, net
209

 

 

 
466

 

 
675

Intercompany accounts receivable
170

 
74

 

 
605

 
(849
)
 

Intercompany loans receivable - current portion
221

 

 

 
354

 
(575
)
 

Inventories:
 
 
 
 
 
 
 
 
 
 
 
Finished and in-process goods
119

 

 

 
187

 

 
306

Raw materials and supplies
47

 

 

 
77

 

 
124

Other current assets
35

 

 

 
52

 

 
87

Total current assets
1,026

 
74

 

 
1,857

 
(1,424
)
 
1,533

Investment in unconsolidated entities
182

 

 
28

 
32

 
(193
)
 
49

Deferred income taxes
370

 

 

 
10

 

 
380

Other assets, net
33

 
63

 
2

 
34

 

 
132

Intercompany loans receivable
1,149

 
3,362

 
29

 
3,849

 
(8,389
)
 

Property and equipment, net
490

 

 

 
641

 

 
1,131

Goodwill
93

 

 

 
73

 

 
166

Other intangible assets, net
50

 

 

 
36

 

 
86

Total assets
$
3,393

 
$
3,499

 
$
59

 
$
6,532

 
$
(10,006
)
 
$
3,477

Liabilities and (Deficit) Equity
 
 
 
 
 
 
 
 
 
 
 
Current liabilities:
 
 
 
 
 
 
 
 
 
 
 
Accounts payable
$
171

 
$

 
$

 
$
358

 
$

 
$
529

Intercompany accounts payable
116

 
6

 

 
727

 
(849
)
 

Debt payable within one year
20

 

 

 
58

 

 
78

Intercompany loans payable within one year
200

 

 

 
375

 
(575
)
 

Interest payable
9

 
73

 

 
1

 

 
83

Income taxes payable
2

 

 

 
6

 

 
8

Accrued payroll and incentive compensation
11

 

 

 
31

 

 
42

Other current liabilities
59

 

 

 
59

 

 
118

Total current liabilities
588

 
79

 

 
1,615

 
(1,424
)
 
858

Long-term liabilities:
 
 
 
 
 
 
 
 
 
 
 
Long-term debt
309

 
3,327

 

 
69

 

 
3,705

Intercompany loans payable
3,394

 

 
7

 
4,988

 
(8,389
)
 

Accumulated losses of unconsolidated subsidiaries in excess of investment
470

 

 
108

 

 
(578
)
 

Long-term pension and post employment benefit obligations
92

 

 

 
219

 

 
311

Deferred income taxes
1

 
2

 

 
15

 

 
18

Other long-term liabilities
124

 
6

 

 
40

 

 
170

Total liabilities
4,978

 
3,414

 
115

 
6,946

 
(10,391
)
 
5,062

Total (deficit) equity
(1,585
)
 
85

 
(56
)
 
(414
)
 
385

 
(1,585
)
Total liabilities and (deficit) equity
$
3,393

 
$
3,499

 
$
59

 
$
6,532

 
$
(10,006
)
 
$
3,477



MOMENTIVE SPECIALTY CHEMICALS INC.
DECEMBER 31, 2012
CONDENSED CONSOLIDATING BALANCE SHEET
  
 
Momentive
Specialty
Chemicals
Inc.
 
Subsidiary
Issuers
 
Combined
Subsidiary
Guarantors
 
Combined
Non-Guarantor
Subsidiaries
 
Eliminations
 
Consolidated
Assets
 
 
 
 
 
 
 
 
 
 
 
Current assets
 
 
 
 
 
 
 
 
 
 
 
Cash and cash equivalents (including restricted cash of $0 and $18, respectively)
$
276

 
$

 
$

 
$
143

 
$

 
$
419

Short-term investments

 

 

 
5

 

 
5

Accounts receivable, net
177

 

 

 
350

 

 
527

Intercompany accounts receivable
126

 
52

 

 
318

 
(496
)
 

Intercompany loans receivable - current portion
162

 

 

 
624

 
(786
)
 

Inventories:
 
 
 
 
 
 
 
 
 
 
 
Finished and in-process goods
109

 

 

 
153

 

 
262

Raw materials and supplies
35

 

 

 
70

 

 
105

Other current assets
38

 

 

 
43

 

 
81

Total current assets
923

 
52

 

 
1,706

 
(1,282
)
 
1,399

Investment in unconsolidated entities
252

 

 
42

 
18

 
(270
)
 
42

Deferred income taxes
337

 

 

 
11

 

 
348

Other assets, net

 
42

 
28

 
39

 

 
109

Intercompany loans receivable
773

 
2,273

 
27

 
3,835

 
(6,908
)
 

Property and equipment, net
493

 

 

 
674

 

 
1,167

Goodwill
93

 

 

 
76

 

 
169

Other intangible assets, net
53

 

 

 
38

 

 
91

Total assets
$
2,924

 
$
2,367

 
$
97

 
$
6,397

 
$
(8,460
)
 
$
3,325

Liabilities and (Deficit) Equity
 
 
 
 
 
 
 
 
 
 
 
Current liabilities:
 
 
 
 
 
 
 
 
 
 
 
Accounts payable
$
136

 
$

 
$

 
$
282

 
$

 
$
418

Intercompany accounts payable
96

 
4

 
1

 
395

 
(496
)
 

Debt payable within one year
13

 

 

 
63

 

 
76

Intercompany loans payable within one year
197

 

 

 
589

 
(786
)
 

Interest payable
12

 
51

 

 

 

 
63

Income taxes payable
3

 

 

 
1

 

 
4

Accrued payroll and incentive compensation
14

 

 

 
26

 

 
40

Other current liabilities
64

 

 

 
65

 

 
129

Total current liabilities
535

 
55

 
1

 
1,421

 
(1,282
)
 
730

Long term liabilities:
 
 
 
 
 
 
 
 
 
 
 
Long-term debt
860

 
2,138

 

 
421

 

 
3,419

Intercompany loans payable
2,303

 
4

 
7

 
4,594

 
(6,908
)
 

Accumulated losses of unconsolidated subsidiaries in excess of investment
325

 

 
107

 

 
(432
)
 

Long-term pension and post employment benefit obligations
98

 

 

 
211

 

 
309

Deferred income taxes

 
1

 

 
17

 

 
18

Other long-term liabilities
120

 
6

 

 
40

 

 
166

Total liabilities
4,241

 
2,204

 
115

 
6,704

 
(8,622
)
 
4,642

Total (deficit) equity
(1,317
)
 
163

 
(18
)
 
(307
)
 
162

 
(1,317
)
Total liabilities and (deficit) equity
$
2,924

 
$
2,367

 
$
97

 
$
6,397

 
$
(8,460
)
 
$
3,325

MOMENTIVE SPECIALTY CHEMICALS INC.
THREE MONTHS ENDED JUNE 30, 2013
CONDENSED CONSOLIDATING STATEMENT OF OPERATIONS (Unaudited)
 
 
Momentive
Specialty
Chemicals
Inc.
 
Subsidiary
Issuers
 
Combined
Subsidiary
Guarantors
 
Combined
Non-Guarantor
Subsidiaries
 
Eliminations
 
Consolidated
Net sales
$
572

 
$

 
$

 
$
729

 
$
(51
)
 
$
1,250

Cost of sales
485

 

 

 
664

 
(51
)
 
1,098

Gross profit
87

 

 

 
65

 

 
152

Selling, general and administrative expense
29

 

 

 
60

 

 
89

Asset impairments

 

 

 
7

 

 
7

Business realignment costs
2

 

 

 

 

 
2

Other operating (income) expense, net
(1
)
 

 

 
6

 

 
5

Operating income (loss)
57

 

 

 
(8
)
 

 
49

Interest expense, net
8

 
67

 

 
1

 

 
76

Intercompany interest expense (income)
47

 
(67
)
 

 
20

 

 

Other non-operating (income) expense, net
(8
)
 

 

 
6

 

 
(2
)
Income (loss) before income tax and (losses) earnings from unconsolidated entities
10

 

 

 
(35
)
 

 
(25
)
Income tax (benefit) expense
(4
)
 

 

 
10

 

 
6

Income (loss) before (losses) earnings from unconsolidated entities
14

 

 

 
(45
)
 

 
(31
)
(Losses) earnings from unconsolidated entities, net of taxes
(42
)
 

 
(17
)
 
1

 
61

 
3

Net loss
$
(28
)
 
$

 
$
(17
)
 
$
(44
)
 
$
61

 
$
(28
)
Comprehensive (loss) income
$
(43
)
 
$
1

 
$
(16
)
 
$
(62
)
 
$
77

 
$
(43
)

MOMENTIVE SPECIALTY CHEMICALS INC.
THREE MONTHS ENDED JUNE 30, 2012
CONDENSED CONSOLIDATING STATEMENT OF OPERATIONS (Unaudited)
 
 
Momentive
Specialty
Chemicals
Inc.
 
Subsidiary
Issuers
 
Combined
Subsidiary
Guarantors
 
Combined
Non-Guarantor
Subsidiaries
 
Eliminations
 
Consolidated
Net sales
$
576

 
$

 
$

 
$
761

 
$
(78
)
 
$
1,259

Cost of sales
484

 

 

 
682

 
(78
)
 
1,088

Gross profit
92

 

 

 
79

 

 
171

Selling, general and administrative expense
17

 

 

 
62

 

 
79

Business realignment costs
2

 

 

 
1

 

 
3

Other operating (income) expense, net
(4
)
 

 

 
1

 

 
(3
)
Operating income
77

 

 

 
15

 

 
92

Interest expense, net
14

 
46

 

 
7

 

 
67

Intercompany interest expense (income)
35

 
(49
)
 

 
14

 

 

Other non-operating expense (income), net
22

 

 
1

 
(24
)
 

 
(1
)
Income (loss) before income tax and earnings from unconsolidated entities
6

 
3

 
(1
)
 
18

 

 
26

Income tax expense
3

 

 

 
1

 

 
4

Income (loss) before earnings from unconsolidated entities
3

 
3

 
(1
)
 
17

 

 
22

Earnings from unconsolidated entities, net of taxes
25

 

 
5

 
2

 
(26
)
 
6

Net income
$
28

 
$
3

 
$
4

 
$
19

 
$
(26
)
 
$
28

Comprehensive (loss) income
$
(15
)
 
$

 
$
5

 
$
(2
)
 
$
(3
)
 
$
(15
)

MOMENTIVE SPECIALTY CHEMICALS INC.
SIX MONTHS ENDED JUNE 30, 2013
CONDENSED CONSOLIDATING STATEMENT OF OPERATIONS (Unaudited)
 
 
Momentive
Specialty
Chemicals
Inc.
 
Subsidiary
Issuers
 
Combined
Subsidiary
Guarantors
 
Combined
Non-Guarantor
Subsidiaries
 
Eliminations
 
Consolidated
Net sales
$
1,109

 
$

 
$

 
$
1,437

 
$
(104
)
 
$
2,442

Cost of sales
949

 

 

 
1,302

 
(104
)
 
2,147

Gross profit
160

 

 

 
135

 

 
295

Selling, general and administrative expense
57

 

 

 
124

 

 
181

Asset impairments

 

 

 
7

 

 
7

Business realignment costs
6

 

 

 
5

 

 
11

Other operating expense (income), net
3

 
(4
)
 

 
3

 

 
2

Operating income (loss)
94

 
4

 

 
(4
)
 

 
94

Interest expense, net
18

 
128

 

 
4

 

 
150

Intercompany interest expense (income)
91

 
(130
)
 

 
39

 

 

Loss on extinguishment of debt
2

 

 

 
4

 

 
6

Other non-operating expense (income), net
7

 

 

 
(4
)
 

 
3

(Loss) income before income tax and (losses) earnings from unconsolidated entities
(24
)
 
6

 

 
(47
)
 

 
(65
)
Income tax (benefit) expense
(42
)
 
1

 

 
15

 

 
(26
)
Income (loss) before (losses) earnings from unconsolidated entities
18

 
5

 

 
(62
)
 

 
(39
)
(Losses) earnings from unconsolidated entities, net of taxes
(50
)
 

 
(23
)
 
2

 
78

 
7

Net (loss) income
$
(32
)
 
$
5

 
$
(23
)
 
$
(60
)
 
$
78

 
$
(32
)
Comprehensive (loss) income
$
(60
)
 
$
5

 
$
(23
)
 
$
(78
)
 
$
96

 
$
(60
)

MOMENTIVE SPECIALTY CHEMICALS INC.
SIX MONTHS ENDED JUNE 30, 2012
CONDENSED CONSOLIDATING STATEMENT OF OPERATIONS (Unaudited)
 
 
Momentive
Specialty
Chemicals
Inc.
 
Subsidiary
Issuers
 
Combined
Subsidiary
Guarantors
 
Combined
Non-Guarantor
Subsidiaries
 
Eliminations
 
Consolidated
Net sales
$
1,114

 
$

 
$

 
$
1,530

 
$
(149
)
 
$
2,495

Cost of sales
942

 

 

 
1,359

 
(149
)
 
2,152

Gross profit
172

 

 

 
171

 

 
343

Selling, general and administrative expense
47

 

 

 
117

 

 
164

Asset impairments

 

 

 
23

 

 
23

Business realignment costs
4

 

 

 
14

 

 
18

Other operating (income) expense, net
(3
)
 

 

 
5

 

 
2

Operating income
124

 

 

 
12

 

 
136

Interest expense, net
30

 
85

 

 
17

 

 
132

Intercompany interest expense (income)
65

 
(91
)
 

 
26

 

 

Other non-operating expense (income), net
11

 

 

 
(10
)
 

 
1

Income (loss) before income tax and (losses) earnings from unconsolidated entities
18

 
6

 

 
(21
)
 

 
3

Income tax expense
2

 

 

 

 

 
2

Income (loss) before (losses) earnings from unconsolidated entities
16

 
6

 

 
(21
)
 

 
1

(Losses) earnings from unconsolidated entities, net of taxes
(4
)
 

 
3

 
2

 
10

 
11

Net income (loss)
$
12

 
$
6

 
$
3

 
$
(19
)
 
$
10

 
$
12

Comprehensive (loss) income
$
(2
)
 
$
4

 
$
4

 
$
(23
)
 
$
15

 
$
(2
)
MOMENTIVE SPECIALTY CHEMICALS INC.
SIX MONTHS ENDED JUNE 30, 2013
CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS (Unaudited)
 
 
Momentive
Specialty
Chemicals
Inc.
 
Subsidiary
Issuers
 
Combined
Subsidiary
Guarantors
 
Combined
Non-Guarantor
Subsidiaries
 
Eliminations
 
Consolidated
Cash flows provided by (used in) operating activities
$
7

 
$
1

 
$
13

 
$
9

 
$
(95
)
 
$
(65
)
Cash flows provided by (used in) investing activities
 
 
 
 
 
 
 
 
 
 
 
Capital expenditures
(29
)
 

 

 
(31
)
 

 
(60
)
Capitalized interest

 

 

 
(1
)
 

 
(1
)
Purchases of debt securities, net

 

 

 
(1
)
 

 
(1
)
Capital contribution to subsidiary
(15
)
 

 
(10
)
 

 
25

 

Change in restricted cash

 

 

 
15

 

 
15

Investment in unconsolidated affiliates, net

 

 

 
(13
)
 

 
(13
)
Proceeds from sale of assets

 

 

 
1

 

 
1

Return of capital from subsidiary from sales of accounts receivable
75

 

 

 

 
(75
)
 

 
31

 

 
(10
)
 
(30
)
 
(50
)
 
(59
)
Cash flows (used in) provided by financing activities
 
 
 
 
 
 
 
 
 
 
 
Net short-term debt borrowings

 

 

 
9

 

 
9

Borrowings of long-term debt

 
1,108

 

 
19

 

 
1,127

Repayments of long-term debt
(544
)
 
(120
)
 

 
(376
)
 

 
(1,040
)
Net intercompany loan borrowings (repayments)
467

 
(882
)
 
(1
)
 
416

 

 

Long-term debt and credit facility financing fees
(12
)
 
(24
)
 

 

 

 
(36
)
Capital contribution from parent

 

 
10

 
15

 
(25
)
 

Common stock dividends paid

 
(83
)
 
(12
)
 

 
95

 

Return of capital to parent from sales of accounts receivable

 

 

 
(75
)
 
75

 

 
(89
)
 
(1
)
 
(3
)
 
8

 
145

 
60

Effect of exchange rates on cash and cash equivalents

 

 

 
(5
)
 

 
(5
)
Decrease in cash and cash equivalents
(51
)
 

 

 
(18
)
 

 
(69
)
Cash and cash equivalents (unrestricted) at beginning of period
276

 

 

 
125

 

 
401

Cash and cash equivalents (unrestricted) at end of period
$
225

 
$

 
$

 
$
107

 
$

 
$
332

MOMENTIVE SPECIALTY CHEMICALS INC.
SIX MONTHS ENDED JUNE 30, 2012
CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS (Unaudited)
 
 
Momentive
Specialty
Chemicals
Inc.
 
Subsidiary
Issuers
 
Combined
Subsidiary
Guarantors
 
Combined
Non-Guarantor
Subsidiaries
 
Eliminations
 
Consolidated
Cash flows provided by (used in) operating activities
$
13

 
$
8

 
$
12

 
$
(25
)
 
$
(18
)
 
$
(10
)
Cash flows provided by (used in) investing activities
 
 
 
 
 
 
 
 
 
 
 
Capital expenditures
(25
)
 

 

 
(33
)
 

 
(58
)
Proceeds from sale of debt securities, net

 

 

 
2

 

 
2

Capital contribution to subsidiary
(15
)
 

 
(10
)
 

 
25

 

Funds remitted to unconsolidated affiliates

 

 

 
(3
)
 

 
(3
)
Proceeds from sale of assets
9

 

 

 

 

 
9

Return of capital from subsidiary from sales of accounts receivable
42

 

 

 

 
(42
)
 

 
11

 

 
(10
)
 
(34
)
 
(17
)
 
(50
)
Cash flows provided by (used in) financing activities
 
 
 
 
 
 
 
 
 
 
 
Net short-term debt repayments

 

 

 
(15
)
 

 
(15
)
Borrowings of long-term debt

 
450

 

 
1

 

 
451

Repayments of long-term debt
(272
)
 

 

 
(201
)
 

 
(473
)
Net intercompany loan borrowings (repayments)
270

 
(439
)
 
(2
)
 
171

 

 

Long-term debt and credit facility financing fees
(2
)
 
(11
)
 

 

 

 
(13
)
Capital contribution from parent
16

 

 
10

 
15

 
(25
)
 
16

Common stock dividends paid
(2
)
 
(8
)
 
(10
)
 

 
18

 
(2
)
Return of capital to parent from sales of accounts receivable

 

 

 
(42
)
 
42

 

 
10

 
(8
)
 
(2
)
 
(71
)
 
35

 
(36
)
Effect of exchange rates on cash and cash equivalents

 

 

 
2

 

 
2

Increase (decrease) in cash and cash equivalents
34

 

 

 
(128
)
 

 
(94
)
Cash and cash equivalents (unrestricted) at beginning of period
212

 

 

 
204

 

 
416

Cash and cash equivalents (unrestricted) at end of period
$
246

 
$

 
$

 
$
76

 
$

 
$
322